Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Total Liabilities (2016 - 2025)

United States Antimony (UAMY) has disclosed Total Liabilities for 15 consecutive years, with $13.0 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 114.67% to $13.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.0 million through Dec 2025, up 114.67% year-over-year, with the annual reading at $13.0 million for FY2025, 114.67% up from the prior year.
  • Total Liabilities hit $13.0 million in Q4 2025 for United States Antimony, up from $8.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $13.0 million in Q4 2025 to a low of $1.5 million in Q2 2023.
  • Historically, Total Liabilities has averaged $4.1 million across 5 years, with a median of $2.6 million in 2021.
  • Biggest five-year swings in Total Liabilities: crashed 57.74% in 2021 and later skyrocketed 209.61% in 2025.
  • Year by year, Total Liabilities stood at $2.6 million in 2021, then rose by 7.49% to $2.8 million in 2022, then fell by 9.08% to $2.6 million in 2023, then skyrocketed by 134.73% to $6.0 million in 2024, then surged by 114.67% to $13.0 million in 2025.
  • Business Quant data shows Total Liabilities for UAMY at $13.0 million in Q4 2025, $8.1 million in Q3 2025, and $10.0 million in Q2 2025.